Amylyx Pharmaceuticals (AMLX)
(Delayed Data from NSDQ)
$7.84 USD
-0.35 (-4.27%)
Updated Aug 7, 2025 04:00 PM ET
After-Market: $7.84 0.00 (0.00%) 5:32 PM ET
3-Hold of 5 3
F Value C Growth D Momentum D VGM
Fundamental Charts
About Dividend Yield (TTM)
Amylyx Pharmaceuticals, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Drugs industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
AMLX 7.84 -0.35(-4.27%)
Will AMLX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for AMLX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AMLX
Wall Street Analysts See a 105.22% Upside in Amylyx Pharmaceuticals (AMLX): Can the Stock Really Move This High?
PSTV Stock Skyrockets on FDA's Orphan Drug Tag for Cancer Therapy
AMLX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Amylyx Pharmaceuticals (AMLX) Upgraded to Buy: What Does It Mean for the Stock?
Other News for AMLX
Which under-the-radar winners have the best chance for further gains?
Amylyx Pharmaceuticals Reports Second Quarter 2025 Financial Results | AMLX Stock News
Amylyx reports Q2 EPS (46c), consensus (45c)
Amylyx Pharmaceuticals GAAP EPS of -$0.46 misses by $0.01
Here are the major earnings before the open Thursday